Table 2.
Frequency of ACA.
| Karyotypes | Single ACA | In combination with other ACA | Total |
|---|---|---|---|
| High-risk ACA (n = 91)a | |||
| +8 | 19 | 19 | 38 |
| At diagnosis | 6 | 10 | 16 |
| In the course of disease | 13 | 9 | 22 |
| +Ph | 18 | 17 | 35 |
| At diagnosis | 7 | 6 | 13 |
| In the course of disease | 11 | 11 | 22 |
| +19 | 0 | 11 | 11 |
| At diagnosis | 0 | 4 | 4 |
| In the course of disease | 0 | 7 | 7 |
| +17/i(17q) | 3 | 5 | 8 |
| At diagnosis | 1 | 3 | 4 |
| In the course of disease | 2 | 2 | 4 |
| 3q26.2 | 10 | 2 | 12 |
| At diagnosis | 1 | 0 | 1 |
| In the course of disease | 9 | 2 | 9 |
| −7/7q abnormalities | 5 | 4 | 9 |
| At diagnosis | 1 | 0 | 1 |
| In the course of disease | 4 | 4 | 8 |
| +21 | 2 | 3 | 5 |
| At diagnosis | 1 | 1 | 2 |
| In the course of disease | 1 | 2 | 3 |
| 11q23 | 1 | 0 | 1 |
| At diagnosis | 0 | 0 | 0 |
| In the course of disease | 1 | 0 | 1 |
| Complex karyotypes | 25 | 25 | |
| At diagnosis | 11 | 11 | |
| In the course of disease | 14 | 14 | |
| Low-risk ACA | 32 | 32 | |
| At diagnosis | 19 | 19 | |
| In the course of disease | 13 | 13 |
aMultiple listings possible.